Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120


Voluntary co-consumption of alcohol and nicotine: Effects of abstinence, intermittency, and withdrawal in mice.

O'Rourke KY, Touchette JC, Hartell EC, Bade EJ, Lee AM.

Neuropharmacology. 2016 Oct;109:236-46. doi: 10.1016/j.neuropharm.2016.06.023. Epub 2016 Jun 21.


Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence.

Hillmer AT, Kloczynski T, Sandiego CM, Pittman B, Anderson JM, Labaree D, Gao H, Huang Y, Deluliis G, O'Malley SS, Carson RE, Cosgrove KP.

Alcohol Clin Exp Res. 2016 Apr;40(4):698-705. doi: 10.1111/acer.12997. Epub 2016 Mar 12.


Human pharmacology for addiction medicine: From evidence to clinical recommendations.

Quednow BB, Herdener M.

Prog Brain Res. 2016;224:227-50. doi: 10.1016/bs.pbr.2015.07.017. Epub 2015 Oct 27.


Targeting glutamate homeostasis for potential treatment of nicotine dependence.

Alasmari F, Al-Rejaie SS, AlSharari SD, Sari Y.

Brain Res Bull. 2016 Mar;121:1-8. doi: 10.1016/j.brainresbull.2015.11.010. Epub 2015 Nov 14. Review.


Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, cocaine, opioid, and cannabis use: A focused review.

Garcia AN, Salloum IM.

Am J Addict. 2015 Oct;24(7):590-8. doi: 10.1111/ajad.12291. Epub 2015 Sep 8. Review.


The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents.

Vallöf D, Maccioni P, Colombo G, Mandrapa M, Jörnulf JW, Egecioglu E, Engel JA, Jerlhag E.

Addict Biol. 2016 Mar;21(2):422-37. doi: 10.1111/adb.12295. Epub 2015 Aug 25.


The role of conduct disorder in the relationship between alcohol, nicotine and cannabis use disorders.

Grant JD, Lynskey MT, Madden PA, Nelson EC, Few LR, Bucholz KK, Statham DJ, Martin NG, Heath AC, Agrawal A.

Psychol Med. 2015 Dec;45(16):3505-15. doi: 10.1017/S0033291715001518. Epub 2015 Aug 18.


Effect of drugs of abuse on social behaviour: a review of animal models.

Blanco-Gandía MC, Mateos-García A, García-Pardo MP, Montagud-Romero S, Rodríguez-Arias M, Miñarro J, Aguilar MA.

Behav Pharmacol. 2015 Sep;26(6):541-70. doi: 10.1097/FBP.0000000000000162. Review.


Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.

Jackson KJ, Jackson A, Carroll FI, Damaj MI.

Neuropharmacology. 2015 Oct;97:270-4. doi: 10.1016/j.neuropharm.2015.05.023. Epub 2015 Jun 1.


KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.

Padula AE, Griffin WC 3rd, Lopez MF, Nimitvilai S, Cannady R, McGuier NS, Chesler EJ, Miles MF, Williams RW, Randall PK, Woodward JJ, Becker HC, Mulholland PJ.

Neuropsychopharmacology. 2015 Jul;40(8):1928-39. doi: 10.1038/npp.2015.42. Epub 2015 Feb 9.


Adolescent alcohol exposure: Are there separable vulnerable periods within adolescence?

Spear LP.

Physiol Behav. 2015 Sep 1;148:122-30. doi: 10.1016/j.physbeh.2015.01.027. Epub 2015 Jan 23. Review.


Real-time patterns of smoking and alcohol use: an observational study protocol of risky-drinking smokers.

Cohn A, Brandon T, Armeli S, Ehlke S, Bowers M.

BMJ Open. 2015 Jan 6;5(1):e007046. doi: 10.1136/bmjopen-2014-007046.


Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME.

J Med Toxicol. 2014 Dec;10(4):369-81. doi: 10.1007/s13181-014-0430-3. Review.


Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell.

Truitt WA, Hauser SR, Deehan GA Jr, Toalston JE, Wilden JA, Bell RL, McBride WJ, Rodd ZA.

Psychopharmacology (Berl). 2015 Feb;232(3):639-49. doi: 10.1007/s00213-014-3702-3. Epub 2014 Aug 26.


Varenicline in the treatment of alcohol use disorders.

Erwin BL, Slaton RM.

Ann Pharmacother. 2014 Nov;48(11):1445-55. doi: 10.1177/1060028014545806. Epub 2014 Aug 5. Review.


Time-course of extracellular nicotine and cotinine levels in rat brain following administration of nicotine: effects of route and ethanol coadministration.

Katner SN, Toalston JE, Smoker MP, Rodd ZA, McBride WJ, Engleman EA.

Psychopharmacology (Berl). 2015 Feb;232(3):551-60. doi: 10.1007/s00213-014-3681-4. Epub 2014 Jul 20.


Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives.

Melis M, Pistis M.

Pharmacol Res. 2014 Aug;86:42-9. doi: 10.1016/j.phrs.2014.03.009. Epub 2014 Apr 1. Review.


Larval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatment.

Cousin MA, Ebbert JO, Wiinamaki AR, Urban MD, Argue DP, Ekker SC, Klee EW.

PLoS One. 2014 Mar 21;9(3):e90467. doi: 10.1371/journal.pone.0090467. eCollection 2014.


Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India.

Anantharaman D, Chabrier A, Gaborieau V, Franceschi S, Herrero R, Rajkumar T, Samant T, Mahimkar MB, Brennan P, McKay JD.

PLoS One. 2014 Feb 5;9(2):e88240. doi: 10.1371/journal.pone.0088240. eCollection 2014.


[Medicinal plants in the phytotherapy of alcohol or nicotine addiction. Implication for plants in vitro cultures].

Ozarowski M, Mikołajczak PŁ, Thiem B.

Przegl Lek. 2013;70(10):869-74. Review. Polish.


Supplemental Content

Loading ...
Support Center